9,534 results match your criteria Revue Medicale Suisse [Journal]


Agir sur la planification médicale.

Authors:
Michel Matter

Rev Med Suisse 2019 Apr;15(647):848

Président de l'AMG Rue Micheli-du-Crest 12, 1205 Genève.

View Article

Download full-text PDF

Source

Miscellanées virologiques et politiques, vapoteuses et tabagiques.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(647):846-847

View Article

Download full-text PDF

Source

 : questions-réponses entre patients et médecins.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(647):844-845

View Article

Download full-text PDF

Source

Aspirine et prévention primaire du risque cardiovasculaire : le pendule s’est-il enfin arrêté ?

Rev Med Suisse 2019 Apr;15(647):844

Service de médecine et des soins intensifs, GHOL, Hôpital de Nyon.

View Article

Download full-text PDF

Source

Frontières brouillées.

Authors:
Michèle Gennart

Rev Med Suisse 2019 Apr;15(647):843

Psychologue-psychothérapeute FSP, Avenue Druey 1, 1018 Lausanne.

View Article

Download full-text PDF

Source

1 avril 2019, aux frontières de l’inhumanité.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(647):842-843

View Article

Download full-text PDF

Source

Néphropathie diabétique - Prise en charge multidisciplinaire du diabète : recommandations pour la pratique clinique.

Rev Med Suisse 2019 Apr;15(647):841

Unité d'évaluation des soins, Institut universitaire de médecine sociale et préventive, Biopôle 2, route de la Corniche 10, 1010 Lausanne.

View Article

Download full-text PDF

Source

[Menopausal hormone therapy. Effects on bone and body composition].

Rev Med Suisse 2019 Apr;15(647):836-839

Centre des maladies osseuses, Département de l'appareil locomoteur, CHUV, 1011 Lausanne.

Changes occurring at menopause can be mitigated by prescribing menopausal hormone replacement therapy (HRT). Recent publications from the CoLaus/OsteoLaus cohorts provide important insights into the effects of HRT and after its discontinuation on bone and body composition. HRT has a beneficial effect on bone mineral density, bone microarchitecture and fracture prevention. Read More

View Article

Download full-text PDF

Source
April 2019
3 Reads

[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]

Rev Med Suisse 2019 Apr;15(647):831-835

Service des maladies osseuses, Département de médecine interne, HUG, 1211 Genève 14.

Denosumab discontinuation is associated with a severe rebound effect combining elevation of bone remodeling markers for two years and loss of the gained bone density. In the absence of a potent bisphosphonate prescription at denosumab discontinuation, multiple vertebral fractures are frequent. The median number of vertebral fractures is 5, within 7 to 20 months (median 11) after the last denosumab injection. Read More

View Article

Download full-text PDF

Source

[Bone effects of bisphosphonates and denosumab treatments in breast or prostate cancer].

Authors:
Emmanuel Biver

Rev Med Suisse 2019 Apr;15(647):824-830

Service des maladies osseuses, Département de médecine, HUG et Faculté de médecine, 1211 Genève 14.

Two types of bone diseases can be observed in patients with breast or prostate cancer: fragility fractures related to osteoporosis, and skeletal related events (SRE) complicating bone metastases. Aromatase inhibitors, ovarian function suppression and tamoxifen use in pre-menopausal women, and androgen deprivation therapy, induce a decrease of bone mineral density and an increase of the incidence of fractures, which can be prevented by inhibitors of bone resorption at low doses. In addition, adjuvant bisphosphonates may be associated with benefits on disease free survival, especially regarding bone recurrences, in postmenopausal women with non-metastatic breast cancer. Read More

View Article

Download full-text PDF

Source
April 2019
2 Reads

[Patients with imminent fracture risk : which consequences for their management ?]

Rev Med Suisse 2019 Apr;15(647):821-823

Centre des maladies osseuses, Département de l'appareil locomoteur, CHUV, 1011 Lausanne.

Irrespective of their age, patients with recent fragility fracture have an increased risk of recurrence : this is the imminent fracture risk of multiple origins. As well the vertebral than the non-vertebral fractures are equally predictive of an increased and early fracture risk. Therefore, a fragility fracture is a strong signal for the clinicians to introduce a treatment against osteoporosis. Read More

View Article

Download full-text PDF

Source
April 2019
1 Read

[What can we do at the discovery of an osteroporotic vertebral fracture ?]

Rev Med Suisse 2019 Apr;15(647):815-820

Service de rhumatologie et Centre des maladies osseuses, Département de l'appareil locomoteur, CHUV, 1011 Lausanne.

Osteoporotic vertebral fractures (VF) are common and can induce acute and chronic pain, having a negative impact on quality of life and lifespan. One man and one women over five will have one or more osteoporotic VF after the age of 50. The screening of these fractures is important because they are predictive of subsequent fractures. Read More

View Article

Download full-text PDF

Source
April 2019
2 Reads

[Orthogeriatric care : what specificities ?]

Rev Med Suisse 2019 Apr;15(647):810-814

Service des maladies osseuses, Département de médecine, HUG, 1211 Genève 14.

Hip fracture in the elderly is associated with an increase in disability and mortality. Early intervention programs accelerate the recovery period and reduce mortality. The intervention of geriatricians, with direct responsibility during the acute phase, has demonstrated an optimal benefit, as well as joint management by a geriatrician and an orthopedist. Read More

View Article

Download full-text PDF

Source
April 2019
1 Read

Ostéoporose : une urgence.

Rev Med Suisse 2019 Apr;15(647):807-808

Service des maladies osseuses, Département de médecine interne, HUG, Genève.

View Article

Download full-text PDF

Source

Nutrition :tout et n’importe quoi.

Authors:
Bertrand Kiefer

Rev Med Suisse 2019 Apr;15(646):804

View Article

Download full-text PDF

Source

Miscellanées finales, tuberculeuses et fertiles.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(646):802-803

View Article

Download full-text PDF

Source

Homéopathie : voici comment la France va en finir avec son remboursement.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(646):800-801

View Article

Download full-text PDF

Source

Combiner un AVK et de l’aspirine : un mariage de raison ou de déraison ?

Authors:
Nicolas Blondel

Rev Med Suisse 2019 Apr;15(646):800

HFR Fribourg - Hôpital cantonal.

View Article

Download full-text PDF

Source

La recherche du temps perdu.

Authors:
Christophe Luthy

Rev Med Suisse 2019 Apr;15(646):799

Service de médecine interne de réhabilitation de Beau-Séjour, HUG, 1211 Genève 14.

View Article

Download full-text PDF

Source

Papillomavirus : la France parviendra-t-elle à s’immuniser ?

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(646):798-799

View Article

Download full-text PDF

Source

[Update on the use of steroids in infectious diseases].

Rev Med Suisse 2019 Apr;15(646):792-796

Service des maladies infectieuses, HUG, 1211 Genève 14.

It is well established in daily clinical practice, on the basis of randomized studies, to add corticosteroïds to the antibiotherapy in cases of S. pneumoniae H. influenzae meningitis, tuberculous meningitis and Pneumocystis jiroveci pneumonia in HIV patients. Read More

View Article

Download full-text PDF

Source
April 2019
1 Read

[Diphtheria: new clinical presentations of an old disease].

Rev Med Suisse 2019 Apr;15(646):786-790

Laboratoire de bactériologie, Service de médecine de laboratoire, Département diagnostique, HUG, 1211 Genève 14.

Diphtheria is reappearing in a typical cutaneous form where pre-existing skin lesions (wounds or insect bites) become pustular and turn into painful non-healing ulcers. This form is more common among migrants and disadvantaged populations. Lesions can be caused by strains of toxigenic and non-toxigenic Corynebacteria and among them the famous Corynebacterium diphtheriae. Read More

View Article

Download full-text PDF

Source

[Animal and human bites : what to do and what to know ?]

Rev Med Suisse 2019 Apr;15(646):780-785

Service des maladies infectieuses, HUG, 1211 Genève 14.

Animal and human bites are a common cause of admission to the emergency room and the infections are common, although they are often trivialized. Complications can range from simple cellulitis to septic shock especially in asplenic patients with Capnoyctophaga canimorsus infection. Other less common infections are possible such as rat-bite fever, leptospirosis, tularemia, and evaluation of post-exposure prophylaxis (anti-tetanus, anti-rabies, HIV, HBV) is essential. Read More

View Article

Download full-text PDF

Source
April 2019
1 Read

[Customised infectiology - Fecal microbiota transplantation : following the pathway].

Rev Med Suisse 2019 Apr;15(646):776-779

Service des maladies infectieuses, CHUV, 1011 Lausanne.

Fecal microbiota transplantation (FMT) raised, in the recent years, a growing interest, mostly in Clostridioides difficile infections (CDI). The concept of FMT is quite simple based on the administration of fecal matter from a healthy donor to a patient with a disease related to the gut microbiota imbalance (dysbiosis). Although the theory seems straightforward, the fine mechanisms are multiple and not yet completely understood. Read More

View Article

Download full-text PDF

Source
April 2019
1 Read

[Customised infectiology - Phage therapy: from theory to clinical evidence].

Rev Med Suisse 2019 Apr;15(646):771-775

Département de microbiologie fondamentale, Université de Lausanne, 1004 Lausanne.

Phages are viruses able to specifically infect and lyse target bacteria. The use of phages in the treatment of bacterial infections has been limited due of the development of antibiotics since the 1950's. However, phagotherapy is now gaining more interest due to the emergence of multidrug resistant bacteria. Read More

View Article

Download full-text PDF

Source

[Customised infectiology - Immunogenetics].

Rev Med Suisse 2019 Apr;15(646):766-770

Service des maladies infectieuses, CHUV, 1011 Lausanne.

Recent discoveries in innate immunity together with improvements in the analysis of the human genome have led to the identification of factors that make certain individuals more susceptible to infections than other. We know understand why herpes simplex virus I, a virus with a minor burden in most individuals, is responsible for devastating encephalitis in children unable to detect primo-infection of neural cells. A growing number of patients are treated with immunosuppressive drugs in the field of oncology, organ transplantation and immunology. Read More

View Article

Download full-text PDF

Source
April 2019
1 Read

La personnalisation : une approche ancrée dans les gènes de l’infectiologie.

Rev Med Suisse 2019 Apr;15(646):763-764

Service des maladies infectieuses, Département de médecine, CHUV et Université de Lausanne, Lausanne.

View Article

Download full-text PDF

Source
April 2019
1 Read

Inventer la vieillesse.

Authors:
Georges Abraham

Rev Med Suisse 2019 Apr;15(645):760

Avenue Krieg 13, 1208 Genève.

View Article

Download full-text PDF

Source

Miscellanées ensommeillées, stupéfiantes et antidépressives.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(645):758-759

View Article

Download full-text PDF

Source

Demain, les humains génétiquement et définitivement modifiés.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(645):756-757

View Article

Download full-text PDF

Source

L’obésité : facteur de risque de cancer colorectal précoce ?

Rev Med Suisse 2019 Apr;15(645):756

Unisanté, Lausanne.

View Article

Download full-text PDF

Source

Un chemin difficile….

Authors:
Anne Hügli

Rev Med Suisse 2019 Apr;15(645):755

Chemin de Beau-Soleil 22, 1206 Genève.

View Article

Download full-text PDF

Source

Que savoir, en pratique, pour traiter au mieux une hypothyroïdie ?

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Apr;15(645):754-755

View Article

Download full-text PDF

Source

L’ASSM s’engage en faveur d’un système de santé durable.

Authors:
Valérie Clerc

Rev Med Suisse 2019 Apr;15(645):752-753

Secrétaire générale de l'ASSM, Maison des Académies, Laupenstrasse 7, 3001 Berne.

View Article

Download full-text PDF

Source

[Level of knowledge and behavior regarding HIV prevention in a population of migrants].

Rev Med Suisse 2019 Apr;15(645):748-751

Programme santé migrants, Département de médecine communautaire, de premier recours et des urgences, HUG, 1211 Genève 14.

In Geneva an HIV voluntary counselling and testing (VCT) consultation for migrants exists in a primary care center. A semi-structured questionnaire, was filled out during the VCT consultations. 650 questionnaires were analyzed. Read More

View Article

Download full-text PDF

Source

[Importance and specificity of pharmacovigilance in the pediatric population].

Rev Med Suisse 2019 Apr;15(645):743-747

Centre d'information thérapeutique, Centre régional de pharmacovigilance, Service de pharmacologie et toxicologie cliniques, Département APSI, HUG, 1211 Genève 14.

Clinical trials are usually conducted in a limited time and on a selected population, most often excluding children. These clinical trials provide a first safety profile of the drugs, undeniably essential but often partial, highlighting only the most common adverse drug reactions. In addition in pediatrics, due to growth and physiologic maturation, adverse drug reactions may differ between children and adults and extrapolation of data obtained in adults to children, including safety data, may be inaccurate. Read More

View Article

Download full-text PDF

Source

[IgG4 related disease : the Geneva experience​].

Rev Med Suisse 2019 Apr;15(645):736-741

Service d'immunologie et allergologie, Département de médecine, HUG, 1211 Genève 14.

IgG4-related disease is a fibroinflammatory pathology which gathers several disorders with common histological, serological and clinical features. The disease usually manifests itself as a diffuse or localized enlargement of one or several organs that reveals upon histology a dense lymphoplasmatic infiltrate with IgG4 positive plasma cells, a storiform fibrosis and obliterative phlebitis. Serum IgG4 are often but not always increased. Read More

View Article

Download full-text PDF

Source
April 2019
4 Reads

[Evaluation of the new algorithm in ANCA testing].

Rev Med Suisse 2019 Apr;15(645):732-735

Laboratoire d'immunologie et allergologie clinique, Service de médecine de laboratoires, Département diagnostique, HUG, 1211 Genève 14.

Testing for ANCA is useful for the diagnosis and monitoring of disease activity in ANCA associated vasculitis. ANCA testing is also sometimes requested for other indications. The relevance of indirect immunofluorescence in ANCA testing is controversial and has recently been the object of new international recommendations. Read More

View Article

Download full-text PDF

Source
April 2019
5 Reads

[Autoimmune disorders during chronic human immunodeficiency virus (HIV) infection].

Rev Med Suisse 2019 Apr;15(645):723-731

Service d'immunologie et allergie, Département de médecine interne, CHUV, 1011 Lausanne.

Over the years, the challenges of chronic HIV infection have evolved from the management of life-threatening opportunistic infections to chronic noninfectious complications. Nowadays, autoimmune disorders, which are linked to chronic immune dysregulations, have become an important issue in HIV infected patients. Although they mimic disorders and syndromes described in HIV seronegative patients, their frequency and clinical picture may differ considerably. Read More

View Article

Download full-text PDF

Source
April 2019
2 Reads

[The diagnostic challenge of primary immunodeficiencies in adults].

Authors:
Peter Jandus

Rev Med Suisse 2019 Apr;15(645):719-722

Service d'immunologie et d'allergologie, Département de médecine interne, HUG, 1211 Genève 14.

Primary immunodeficiencies (PID) constitute a heterogeneous group of genetic disorders caused by defects in the development and/or function of the immune system resulting in an increased susceptibility to recurrent infections. In addition to a predisposition to infections, PID patients present an increased vulnerability to autoimmunity, lymphoproliferation, allergies and malignancies. Studies performed in the past decade revealed that the prevalence of PID in adults was largely underestimated. Read More

View Article

Download full-text PDF

Source
April 2019
2 Reads

[From isolated cutaneous vasculitis to systemic disease : a diagnostic approach to purpura in the adult patient].

Rev Med Suisse 2019 Apr;15(645):713-718

Service d'immunologie et allergie, Département de médecine interne, CHUV, 1011 Lausanne.

Purpura can be a clinical manifestation of various diseases. The causes of purpura are divided into two main categories: thrombocytopenia and vasculopathies. Cutaneous vasculitis belongs to the latter group. Read More

View Article

Download full-text PDF

Source
April 2019
1 Read

[Allergy to fish].

Rev Med Suisse 2019 Apr;15(645):706-709

Service d'immunologie et allergie, Département de médecine, CHUV, 1011 Lausanne.

Allergic reactions to fish are potentially life-threatening. We detail here various reactions to fish, notably anaphylaxis and food protein induced enterocolitis syndrome, as well as confounders such as reactions to the parasite Anisakis and scombroid poisoning. Most IgE-mediated reactions are directed to β-parvalbumin. Read More

View Article

Download full-text PDF

Source
April 2019
4 Reads

Davantage de silence.

Rev Med Suisse 2019 Apr;15(645):703-704

Service d'immunologie et allergie, CHUV, Lausanne.

View Article

Download full-text PDF

Source

L’illusion du moratoire.

Authors:
Bertrand Kiefer

Rev Med Suisse 2019 Mar;15(644):700

View Article

Download full-text PDF

Source

Miscellanées compagnonniques et ophtalmologiques.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Mar;15(644):698

View Article

Download full-text PDF

Source

De la rougeole, de la vaccination et des convictions écologistes.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Mar;15(644):696-697

View Article

Download full-text PDF

Source

Avantages et inconvénients des opioïdes dans la douleur chronique non cancéreuse.

Authors:
Elodie Dory

Rev Med Suisse 2019 Mar;15(644):696

Unisanté, Lausanne.

View Article

Download full-text PDF

Source

Sante !

Authors:
François Pilet

Rev Med Suisse 2019 Mar;15(644):695

Chemin d'Outé 3, 1896 Vouvry.

View Article

Download full-text PDF

Source

Actualités de la prise en charge des uvéites.

Authors:
Jean-Yves Nau

Rev Med Suisse 2019 Mar;15(644):694-695

View Article

Download full-text PDF

Source

ECG intégré à l’Apple Watch 4 : le Big Data au secours du dépistage de la fibrillation auriculaire ?

Authors:
Patrick Myers

Rev Med Suisse 2019 Mar;15(644):693

Service de chirurgie cardiaque, CHUV, 1011 Lausanne.

View Article

Download full-text PDF

Source